Skip to main content
UHSUniversal Health Services, Inc.Sell5.6·$172.18
SellModerate Confidence
Investment thesis

Universal Health Services trades at a forward P/E of just 5.8x with a reward-to-risk ratio of 7.89 and 33% analyst upside, offering deep value relative to healthcare facility peers, though confirmed downtrend momentum and an elevated put/call ratio of 2.17 create near-term headwinds.

Thesis pillars

  • Deep Value Forward Pe At 5x→Stable
  • Strong Earnings Beat With Analyst Upside→Stable
  • Confirmed Downtrend Death Cross Block↓Deteriorating
  • +1 more pillar — see the Why tab for full reasoning

Pillars as of Jul 3, 2026, based on the 10-K filed Feb 25, 2026

Full reasoning →

Open full analysis

Universal Health Services, Inc. (UHS) Stock Analysis

SellValueQualityModerate Confidence

Healthcare · Medical Care Facilities

Sell if holding. Analyst target reached at $172.18 — A.R:R is negative (-0.1) — price has exceeded the analyst target. Reward from here is too thin for a buy — the engine flags exit. Additional concerns: V7 low-quality RISK_OFF penalty: -0.5 (Q=5.4).

Universal Health Services owns and operates acute care hospitals, behavioral health facilities, and outpatient centers across 40 states, Washington D.C., the United Kingdom, and Puerto Rico, with 375 inpatient and 168 outpatient facilities as of February 2026. Revenue comes from... Read more

$172.18-0.7% A.UpsideScore 5.6/10#19 of 35 Medical Care Facilities
QualityF-score8 / 9FCF yield4.91%
IncomeYield0.45%(5y avg 0.49%)Payout3.26%sustainable
Stop $164.05Analyst target $170.94(reached)A.R:R -0.1:1
Analyst consensus$189.94+10.3%16 analysts
$172.18price
$189.94mean
$166
$212

Sell if holding. Analyst target reached at $172.18 — A.R:R is negative (-0.1) — price has exceeded the analyst target. Reward from here is too thin for a buy — the engine flags exit. Additional concerns: V7 low-quality RISK_OFF penalty: -0.5 (Q=5.4). Chart setup: No clear chart pattern; technical signals are mixed. Score 5.6/10, moderate confidence.

Passes 4/7 gates (clean insider activity, earnings proximity 118d clear, semi cycle peak clear, materials cycle peak clear). Fails on weak momentum and favorable risk/reward ratio. Suitability: moderate.

TrendMatrix Research · upcoming catalyst calendar

Upcoming dated catalysts

Wed, Feb 24, 2027118d to earnings· next earnings call

Thesis

Rewards
Sector modifier (Healthcare): +0.5
Attractive valuation
Margin of safety: 72%
Risks
Analyst target reached - limited upside remaining
V7 low-quality RISK_OFF penalty: -0.5 (Q=5.4)
Consecutive earnings misses (2)

Key Metrics

P/E (TTM)7.0
P/E (Fwd)7.2
Mkt Cap$10.1B
EV/EBITDA5.8
Profit Mgn8.4%
ROE20.9%
Rev Growth8.3%
Beta1.03
Dividend0.45%
Rating analysts25

Quality Signals

Piotroski F8/9MoatNarrow

Options Flow

P/C1.08bearish
IV40%normal
Max Pain$125-27.4% vs spot

Concentration Risks(10-K Item 1A)

  • LOWGeographicNevada17%
    10-K Item 1A: 'Nevada: We own 10 inpatient acute care hospitals ... these facilities contributed 17% of our consolidated net revenues during each of 2025 and 2024'
  • LOWGeographicTexas16%
    10-K Item 1A: 'Texas: We own 7 inpatient acute care hospitals ... these facilities contributed 16% of our consolidated net revenues during each of 2025 and 2024'
  • LOWGeographicCalifornia11%
    10-K Item 1A: 'California: We own 5 inpatient acute care hospitals ... these facilities contributed 11% of our consolidated net revenues during each of 2025 and 2024'

Material Events(8-K, last 90d)

  • 2026-05-21Item 5.02MEDIUM
    Matthew J. Peterson, EVP and President, Behavioral Health, resigned effective June 19, 2026, to pursue an external career opportunity. CEO Marc D. Miller assumes interim responsibilities for the Behavioral Health Care Division; search for permanent replacement underway. No disagreement cited.
    SEC filing →
  • 2026-03-30Item 5.02LOW
    Compensation Committee approved 2026 annual incentive bonus formulae for executive officers and a $1.07 million discretionary cash bonus for Executive Chairman Alan B. Miller for 2025. Routine compensatory arrangement; no departure or appointment.
    SEC filing →

Model-generated analysis — not investment advice. Not a registered investment advisor. Past performance does not guarantee future results. How we score · Editorial policy

Show full disclosure ▾

About TrendMatrix. TrendMatrix is a publisher of general securities research and market commentary. We publish on a regular schedule. All content is the same for every subscriber in a tier — we do not provide personalized investment advice and we do not take into account any individual subscriber's financial situation, investment objectives, risk tolerance, tax situation, or holdings.

Not investment advice. TrendMatrix is not a registered investment adviser. Our content is for informational and educational purposes only. Consult your own licensed investment adviser, broker, or tax professional before making any investment decision.

Conflicts and positions. People who build TrendMatrix, or entities they control, may hold positions, long or short, in securities it covers, and may trade them at any time. Positions are not disclosed individually. Verdicts are generated by an automated model applied by the same rules to every covered stock, and are not adjusted for any position held by the people who build TrendMatrix. We do not accept payment from issuers for coverage.

No paid promotion. TrendMatrix does not accept payment from any issuer, broker, or third party in exchange for coverage of any security.

No fiduciary duty. No fiduciary, advisory, or agency relationship is created between you and TrendMatrix by reading our content or subscribing to our service.

Performance. Past performance is not indicative of future results. Performance figures reflect the published model only and do not reflect any individual subscriber's actual results.

Methodology · Editorial policy & full disclaimer

Rating Breakdown

1 floor-breaker

Price action weak — below key moving averages, no momentum carry. Needs a base before trend-continuation setups apply.static

Macd
0.0
Obv
1.0
Ma Position
1.0
Vol Acceleration
2.5
Rsi
4.5
Volume
10.0
Volume distribution (falling OBV)Below 200-MA, MA slope -3.6%/30d — confirmed downtrendVolume surge (2.5x avg) on selloff
GatesMomentum 3.2<4.5A.R:R -0.1=NEGATIVEExecutive change: officer departure/appointmentInsider activity: OKEARNINGS PROXIMITY 118d clearSEMI CYCLE PEAK CLEARMATERIALS CYCLE PEAK CLEARSuitability: Moderate
RSI
46 · Neutral
↓ 20D MA↓ 50D MA↓ 200D MAGOLDEN CROSSSupport $169.12Resistance $191.58

Price Targets

A.Upside-0.7%
A.R:R-0.1:1

Position Sizing

ConvictionNone
Suggested %0%
Max %0%
RegimeRisk-Off

Risk Alerts

! Target reached (-0.7% upside)
! momentum at 3.2 (below the engine's 4.5 threshold)
! Negative risk/reward — downside exceeds upside

Earnings

B
B
M
M
2/4 beats
Next Earnings2027-02-24 (118d)

Verdict History

reverse chrono — latest first
Loading history...
Verdicts are recorded on every nightly pipeline run. Rows capture transitions (verdict flips, score deltas ≥0.3, entry/TP/SL changes). Rows with a ▶ can be expanded to see the change reason. Aggregate cohort performance is tracked in the recommendation ledger.
Frequently Asked Questions
Is UHS stock a buy right now?

Sell if holding. Analyst target reached at $172.18 — A.R:R is negative (-0.1) — price has exceeded the analyst target. Reward from here is too thin for a buy — the engine flags exit. Additional concerns: V7 low-quality RISK_OFF penalty: -0.5 (Q=5.4). Chart setup: No clear chart pattern; technical signals are mixed. Prior stop was $164.05. Score 5.6/10, moderate confidence.

What is the UHS stock price target?

Analyst target $170.94 reached (−0.7% from $172.18); no take-profit level is published. Prior stop was $164.05. Stop-loss: $164.05.

What are the risks of investing in UHS?

Analyst target reached - limited upside remaining; V7 low-quality RISK_OFF penalty: -0.5 (Q=5.4); Consecutive earnings misses (2).

Is UHS overvalued or undervalued?

Universal Health Services, Inc. trades at a P/E of 7.0 (forward 7.2). TrendMatrix value score: 7.7/10. Verdict: Sell.

What do analysts say about UHS?

25 analysts cover UHS with a consensus score of 3.4/5. Average price target: $190.

What does Universal Health Services, Inc. do?Universal Health Services owns and operates acute care hospitals, behavioral health facilities, and outpatient centers...

Universal Health Services owns and operates acute care hospitals, behavioral health facilities, and outpatient centers across 40 states, Washington D.C., the United Kingdom, and Puerto Rico, with 375 inpatient and 168 outpatient facilities as of February 2026. Revenue comes from Medicare, Medicaid, and private insurers, with acute care generating approximately 57% of consolidated net revenues and behavioral health approximately 43%; U.K. operations contributed approximately $1.0 billion in 2025.

Related stocks: ASTH (Astrana Health Inc.) · AVAH (Aveanna Healthcare Holdings Inc) · CHE (Chemed Corp) · THC (Tenet Healthcare Corporation) · ADUS (Addus HomeCare Corporation)
Home › Stocks › UHS

Latest news

Latest News

Yahoo Finance99d agoEarnings
GuruFocus99d ago
Yahoo Finance190d ago
Yahoo Finance190d agoEarnings
TradingKey134d ago
AD HOC NEWS134d agoAnalyst
Sahm141d ago
Kalkine Media2d ago
Yahoo Finance2d ago
Www.marketscreener.com2d agoEarnings
StockStory2d agoEarnings
TIKR.com2d ago
Marketscreener.com100d ago
TipRanks100d ago
The Globe and Mail191d agoEarnings
TradingView191d agoEarnings
Seeking Alpha9d ago
Yahoo Finance9d agoEarnings
AD HOC NEWS135d agoEarnings
AD HOC NEWS135d ago
Loading more...